Abstract
A pooled analysis was conducted of 1257 toddlers who received a fourth dose of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) or Hib conjugate vaccine (Hib polysaccharide conjugated to N. meningitidis outer membrane protein) coadministered with measles-mumps-rubella (MMR) and varicella (VAR) vaccines (NCT00134719/NCT00289783). Noninferiority of immunological responses to MMR and VAR was demonstrated between groups and incidences of MMR- and VAR-specific solicited symptoms were similar, indicating that HibMenCY-TT can be coadministered with MMR and VAR.
Publication types
-
Meta-Analysis
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Chickenpox Vaccine / administration & dosage
-
Chickenpox Vaccine / adverse effects*
-
Chickenpox Vaccine / immunology*
-
Female
-
Haemophilus Vaccines / administration & dosage
-
Haemophilus Vaccines / adverse effects*
-
Haemophilus Vaccines / immunology*
-
Humans
-
Infant
-
Male
-
Measles-Mumps-Rubella Vaccine / administration & dosage
-
Measles-Mumps-Rubella Vaccine / adverse effects*
-
Measles-Mumps-Rubella Vaccine / immunology*
-
Randomized Controlled Trials as Topic
-
Tetanus Toxoid / administration & dosage
-
Tetanus Toxoid / adverse effects*
-
Tetanus Toxoid / immunology*
-
Vaccines, Conjugate / administration & dosage
-
Vaccines, Conjugate / adverse effects
-
Vaccines, Conjugate / immunology
Substances
-
Chickenpox Vaccine
-
Haemophilus Vaccines
-
Hib-MenCY-TT vaccine
-
Measles-Mumps-Rubella Vaccine
-
Tetanus Toxoid
-
Vaccines, Conjugate
Associated data
-
ClinicalTrials.gov/NCT00134719
-
ClinicalTrials.gov/NCT00289783